Anadys Pharmaceuticals Inc (NASDAQ:ANDS) to Present at JMP Securities Conference May 19

Anadys Pharmaceuticals Inc (NASDAQ:ANDS) will speak at the JMP Securities Research Conference on Monday, May 19 at 6:30 pm ET.  The hour long presentation will be made available on the Anady’s website via webcast at ir.anadyspharma.com.

A biopharmaceutical company, Anadys Pharmaceuticals is focused on the development of medicines in the areas of hepatitis C and oncology.  The company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C and ANA 773, an orall Toll-like receptor 7 (TLR7) agonist prodrug for cancer.  Both ANA 598 and ANA 773 were discovered at Anadys and are wholly owned assets of Anadys.

Find more Conference Calls on Finditt Events.